List of Fibrogen, Inc. patents

Patents where

Current Assignee

Name

Fibrogen, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7618940 Fat regulation	Patent 7618940 was granted and assigned to Fibrogen, Inc. on November, 2009 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	7618940	November 17, 2009
‌ US Patent 7405274 Connective tissue growth factor antibodies	Patent 7405274 was granted and assigned to Fibrogen, Inc. on July, 2008 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	7405274	July 29, 2008
‌ US Patent 9631013 Therapeutic method for pancreatic cancer	Patent 9631013 was granted and assigned to Fibrogen, Inc. on April, 2017 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9631013	April 25, 2017
‌ US Patent 8124582 Treatment of diabetes	Patent 8124582 was granted and assigned to Fibrogen, Inc. on February, 2012 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8124582	February 28, 2012
‌ US Patent 8629131 Enhanced erythropoiesis and iron metabolism	Patent 8629131 was granted and assigned to Fibrogen, Inc. on January, 2014 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8629131	January 14, 2014
‌ US Patent 7323475 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 7323475 was granted and assigned to Fibrogen, Inc. on January, 2008 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	7323475	January 29, 2008
‌ US Patent 11299537 Methods for treatment of motor neuron diseases		Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	11299537	April 12, 2022
‌ US Patent 9920011 Enhanced erythropoiesis and iron metabolism	Patent 9920011 was granted and assigned to Fibrogen, Inc. on March, 2018 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9920011	March 20, 2018
‌ US Patent 10894774 Enhanced erythropoiesis and iron metabolism	Patent 10894774 was granted and assigned to Fibrogen, Inc. on January, 2021 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	10894774	January 19, 2021
‌ US Patent 10927081 Enhanced erythropoiesis and iron metabolism	Patent 10927081 was granted and assigned to Fibrogen, Inc. on February, 2021 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	10927081	February 23, 2021
‌ US Patent 11229637 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 11229637 was granted and assigned to Fibrogen, Inc. on January, 2022 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	11229637	January 25, 2022
‌ US Patent 8927591 Thiochromene derivatives as HIF hydroxylase inhibitors	Patent 8927591 was granted and assigned to Fibrogen, Inc. on January, 2015 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8927591	January 6, 2015
‌ US Patent 10092558 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 10092558 was granted and assigned to Fibrogen, Inc. on October, 2018 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	10092558	October 9, 2018
‌ US Patent 9617218 Crystalline forms of a prolyl hydroxylase inhibitor	Patent 9617218 was granted and assigned to Fibrogen, Inc. on April, 2017 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9617218	April 11, 2017
‌ US Patent 9339527 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 9339527 was granted and assigned to Fibrogen, Inc. on May, 2016 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9339527	May 17, 2016
‌ US Patent 8017625 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 8017625 was granted and assigned to Fibrogen, Inc. on September, 2011 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8017625	September 13, 2011
‌ US Patent 9371288 Crystalline forms of a prolyl hydroxylase inhibitor	Patent 9371288 was granted and assigned to Fibrogen, Inc. on June, 2016 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9371288	June 21, 2016
‌ US Patent 8466172 Stabilization of hypoxia inducible factor (HIF) alpha	Patent 8466172 was granted and assigned to Fibrogen, Inc. on June, 2013 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8466172	June 18, 2013
‌ US Patent 9034643 Connective tissue growth factor antibodies	Patent 9034643 was granted and assigned to Fibrogen, Inc. on May, 2015 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9034643	May 19, 2015
‌ US Patent 9918977 Crystalline forms of a prolyl hydroxylase inhibitor	Patent 9918977 was granted and assigned to Fibrogen, Inc. on March, 2018 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	9918977	March 20, 2018
‌ US Patent 10118897 Crystalline forms of a prolyl hydroxylase inhibitor	Patent 10118897 was granted and assigned to Fibrogen, Inc. on November, 2018 by the United States Patent and Trademark Office.	Fibrogen, Inc.	Fibrogen, Inc.	United States Patent and Trademark Office	10118897	November 6, 2018
‌ US Patent 8324405 Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors	Patent 8324405 was granted and assigned to Fibrogen, Inc. on December, 2012 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8324405	December 4, 2012
‌ US Patent 7871617 Antibodies that bind to a portion of the VWC domain of connective tissue growth factor	Patent 7871617 was granted and assigned to Fibrogen, Inc. on January, 2011 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	7871617	January 18, 2011
‌ US Patent 7863292 Nitrogen-containing heteroaryl compounds and methods of use thereof	Patent 7863292 was granted and assigned to Fibrogen, Inc. on January, 2011 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	7863292	January 4, 2011
‌ US Patent 8952160 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity	Patent 8952160 was granted and assigned to Fibrogen, Inc. on February, 2015 by the United States Patent and Trademark Office.		Fibrogen, Inc.	United States Patent and Trademark Office	8952160	February 10, 2015

Results per page:

79 results

0 selected

79 results

0 selected